Isabel Preeshagul, DO
Memorial Sloan Kettering Cancer Center
Topic Presenter
Biography
Dr. Isabel Preeshagul is thoracic medical oncologist at Memorial Sloan Kettering Cancer Center (MSKCC). As a physician with a strong clinical background and training in 3 different health systems, Dr. Preeshagul is a firm believer in equal access to high-quality cancer care. She is focused on cancer care delivery, access to care and addressing barriers to clinical trial accrual. Her research efforts have been focused on creating collaborative multi-departmental patient-centric care models, addressing barriers to protocol accrual, expanding access, and contributing to the research mission at large. She holds key leadership roles at MSK centered on advancing the quality and efficiency of clinical operations to serve the needs of patients and clinicians. She leads the Clinical Research Regional Care Network Leadership Group, focusing on optimizing research in MSKCC's regional care network by identifying challenges, implementing new workflows, and assessing how they impact patient care. Dr. Preeshagul also serves as the current peer elected MSK regional care network (RCN) representative on the Medical Staff Advisory Council. MSK’s RCN encompasses six sites across New York and New Jersey. In this role, as RCN representative she works to support the needs of clinicians caring for patients across the network and has partnered with physicians across departments, advanced practice providers, nurses, pharmacists, and administrative leaders from ambulatory care to achieve operational excellence. Outside of MSK, Dr. Preeshagul currently serves as the chair of the Lung Cancer Research Foundation’s (LCRF) Education & Engagement Committee, and she hosts the LCRF’s monthly “Together Separately” international webinar offering various education sessions recapping ASCO, clinical trials 101, and more. Her most recent work, A cross-sectional study of support services influencing patient enrollment decisions in clinical trials was presented at the annual ASCO quality care symposium. As a result, she is now focused on developing a patient navigation program to aid in patient/ provider support during the screening, enrolling and initiation clinical trial process. She was also recently invited to join ASCO’s Communication Committee. Dr. Preeshagul hopes to use this platform to leverage her work on addressing barriers to care and clinical trial accrual both nationally and internationally.
Financial Disclosure
astra zeneca
Advisor
pfizer
Advisor
johnson and johnson
Advisor
takeda
Advisor
boehringer ingelheim
Advisor
regeneron
Advisor
abbvie
Advisor